335 related articles for article (PubMed ID: 32871587)
1. Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1-mutated acute myeloid leukemia.
Xiao W; Chan A; Waarts MR; Mishra T; Liu Y; Cai SF; Yao J; Gao Q; Bowman RL; Koche RP; Csete IS; DelGaudio NL; Derkach A; Baik J; Yanis S; Famulare CA; Patel M; Arcila ME; Stahl M; Rampal RK; Tallman MS; Zhang Y; Dogan A; Goldberg AD; Roshal M; Levine RL
Blood; 2021 Mar; 137(10):1377-1391. PubMed ID: 32871587
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.
Wang W; Xu J; Khoury JD; Pemmaraju N; Fang H; Miranda RN; Yin CC; Hussein SE; Jia F; Tang Z; Hu S; Konopleva M; Medeiros LJ; Wang SA
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884435
[TBL] [Abstract][Full Text] [Related]
3. Plasmacytoid dendritic cells proliferation associated with acute myeloid leukemia: phenotype profile and mutation landscape.
Zalmaï L; Viailly PJ; Biichle S; Cheok M; Soret L; Angelot-Delettre F; Petrella T; Collonge-Rame MA; Seilles E; Geffroy S; Deconinck E; Daguindau E; Bouyer S; Dindinaud E; Baunin V; Le Garff-Tavernier M; Roos-Weil D; Wagner-Ballon O; Salaun V; Feuillard J; Brun S; Drenou B; Mayeur-Rousse C; Okamba P; Dorvaux V; Tichionni M; Rose J; Rubio MT; Jacob MC; Raggueneau V; Preudhomme C; Saas P; Ferrand C; Adotevi O; Roumier C; Jardin F; Garnache-Ottou F; Renosi F
Haematologica; 2021 Dec; 106(12):3056-3066. PubMed ID: 33054115
[TBL] [Abstract][Full Text] [Related]
4. Flow Cytometry Identifies a Spectrum of Maturation in Myeloid Neoplasms Having Plasmacytoid Dendritic Cell Differentiation.
Hamadeh F; Awadallah A; Meyerson HJ; Beck RC
Cytometry B Clin Cytom; 2020 Jan; 98(1):43-51. PubMed ID: 30614203
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid dendritic cell expansion in myeloid neoplasms: A novel distinct subset of myeloid neoplasm?
Peng J; He S; Yang X; Huang L; Wei J
Crit Rev Oncol Hematol; 2023 Dec; 192():104186. PubMed ID: 37863402
[TBL] [Abstract][Full Text] [Related]
6. Genetics and Epigenetics in Neoplasms with Plasmacytoid Dendritic Cells.
Renosi F; Callanan M; Lefebvre C
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077669
[TBL] [Abstract][Full Text] [Related]
7. Myeloid Neoplasms with Elevated Plasmacytoid Dendritic Cell Differentiation Reflect the Maturation Process of Dendritic Cells.
Huang Y; Wang Y; Chang Y; Yuan X; Hao L; Shi H; Lai Y; Huang X; Liu Y
Cytometry A; 2020 Jan; 97(1):61-69. PubMed ID: 31876105
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid Dendritic Cells, a Novel Target in Myeloid Neoplasms.
Roussel X; Garnache Ottou F; Renosi F
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884612
[TBL] [Abstract][Full Text] [Related]
9. Elevated frequencies of leukemic myeloid and plasmacytoid dendritic cells in acute myeloid leukemia with the FLT3 internal tandem duplication.
Rickmann M; Krauter J; Stamer K; Heuser M; Salguero G; Mischak-Weissinger E; Ganser A; Stripecke R
Ann Hematol; 2011 Sep; 90(9):1047-58. PubMed ID: 21520003
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cells in the setting of myeloid neoplasms: Diagnostic guide to challenging pathologic presentations.
El Hussein S; Wang W
Br J Haematol; 2023 Mar; 200(5):545-555. PubMed ID: 36606610
[TBL] [Abstract][Full Text] [Related]
11. Plasmacytoid dendritic cell neoplasms.
Lee YJ; Kim Y; Park SH; Jo JC
Blood Res; 2023 Apr; 58(S1):90-95. PubMed ID: 37105563
[TBL] [Abstract][Full Text] [Related]
12. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia.
Song J; Li W; Bai Y; Zhou P; Niu J; Niu X; Liu Y; Liu X; Drokow EK; Sun K; Zhou H
Ann Hematol; 2024 Feb; 103(2):463-473. PubMed ID: 38183444
[TBL] [Abstract][Full Text] [Related]
13. Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report.
Koerber RM; Held SAE; Vonnahme M; Feldmann G; Wenzel J; Gütgemann I; Brossart P; Heine A
J Cancer Res Clin Oncol; 2022 Mar; 148(3):743-748. PubMed ID: 34529129
[TBL] [Abstract][Full Text] [Related]
14. CD303 (BDCA-2) - a potential novel target for therapy in hematologic malignancies.
Wilson NR; Bover L; Konopleva M; Han L; Neelapu S; Pemmaraju N
Leuk Lymphoma; 2022 Jan; 63(1):19-30. PubMed ID: 34486917
[TBL] [Abstract][Full Text] [Related]
15. Tumorous proliferations of plasmacytoid dendritic cells and Langerhans cells associated with acute myeloid leukaemia.
Song HL; Huang WY; Chen YP; Chang KC
Histopathology; 2012 Nov; 61(5):974-83. PubMed ID: 22804228
[TBL] [Abstract][Full Text] [Related]
16. Plasmacytoid Dendritic Cell Infiltration in Acute Myeloid Leukemia.
Zhu L; Wang P; Zhang W; Li Q; Xiong J; Li J; Deng X; Liu Y; Yang C; Kong P; Peng X; Zhong JF; Rao J; Zhang X
Cancer Manag Res; 2020; 12():11411-11419. PubMed ID: 33192098
[TBL] [Abstract][Full Text] [Related]
17. CSF3R Mutations are frequently associated with abnormalities of RUNX1, CBFB, CEBPA, and NPM1 genes in acute myeloid leukemia.
Zhang Y; Wang F; Chen X; Zhang Y; Wang M; Liu H; Cao P; Ma X; Wang T; Zhang J; Zhang X; Lu P; Liu H
Cancer; 2018 Aug; 124(16):3329-3338. PubMed ID: 29932212
[TBL] [Abstract][Full Text] [Related]
18. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
19. RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation.
Kuo MC; Liang DC; Huang CF; Shih YS; Wu JH; Lin TL; Shih LY
Leukemia; 2009 Aug; 23(8):1426-31. PubMed ID: 19282830
[TBL] [Abstract][Full Text] [Related]
20. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm.
Kubota S; Tokunaga K; Umezu T; Yokomizo-Nakano T; Sun Y; Oshima M; Tan KT; Yang H; Kanai A; Iwanaga E; Asou N; Maeda T; Nakagata N; Iwama A; Ohyashiki K; Osato M; Sashida G
Nat Commun; 2019 Apr; 10(1):1653. PubMed ID: 30971697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]